UMIN ID: UMIN000001992
Registered date:21/05/2009
Effects of risedronate and alfacalcidol on parameters of atherosclerosis in type 2 diabetes patients with osteoporosis
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Type 2 diabetes with osteoporosis |
| Date of first enrollment | 2008/04/01 |
| Target sample size | 40 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Treatment with risedronate and alfacalcidol No treatment |
Outcome(s)
| Primary Outcome | Plaque score and abdominal aortic calcification score |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 50years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Female |
| Include criteria | |
| Exclude criteria | Nobody had hepatic or renal dysfunction or nutritional derangements. All patients were free of drugs known to influence bone and calcium metabolism, such as vitamin D, bisphosphonate, or estrogen, up until the time of the study. |
Related Information
| Primary Sponsor | Department of Internal Medicine 1, Shimane University School of Medicine |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Department of Internal Medicine 1, Shimane University School of Medicine |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Japan |
| Telephone | |
| ippei.k@med.shimane-u.ac.jp | |
| Affiliation | Shimane University School of Medicine Internal Medicine 1 |
| scientific contact | |
| Name | Ippei Kanazawa |
| Address | 89-1 Enya-cho, Izumo, Shimane Japan |
| Telephone | |
| Affiliation | Shimane University School of Medicine Internal Medicine 1 |